A detailed history of Barclays PLC transactions in Neogenomics Inc stock. As of the latest transaction made, Barclays PLC holds 230,901 shares of NEO stock, worth $3.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
230,901
Previous 230,901 -0.0%
Holding current value
$3.82 Million
Previous $3.41 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$13.4 - $17.73 $2.28 Million - $3.02 Million
170,218 Added 280.5%
230,901 $3.41 Million
Q2 2024

Aug 14, 2024

SELL
$13.01 - $15.77 $908,826 - $1.1 Million
-69,856 Reduced 53.51%
60,683 $842,000
Q1 2024

May 15, 2024

SELL
$14.06 - $16.79 $1.11 Million - $1.32 Million
-78,788 Reduced 37.64%
130,539 $2.05 Million
Q4 2023

Feb 15, 2024

BUY
$11.67 - $20.73 $1.63 Million - $2.89 Million
139,461 Added 199.61%
209,327 $3.39 Million
Q3 2023

Nov 07, 2023

SELL
$12.15 - $17.85 $43,047 - $63,242
-3,543 Reduced 4.83%
69,866 $859,000
Q2 2023

Aug 03, 2023

BUY
$14.1 - $19.83 $113,970 - $160,285
8,083 Added 12.37%
73,409 $1.18 Million
Q1 2023

May 04, 2023

SELL
$9.09 - $19.45 $241,030 - $515,736
-26,516 Reduced 28.87%
65,326 $1.14 Million
Q4 2022

Feb 13, 2023

BUY
$6.45 - $12.07 $322,183 - $602,908
49,951 Added 119.24%
91,842 $848,000
Q3 2022

Nov 03, 2022

SELL
$7.86 - $12.91 $12.5 Million - $20.6 Million
-1,596,434 Reduced 97.44%
41,891 $361,000
Q2 2022

Aug 12, 2022

BUY
$7.06 - $13.97 $10.8 Million - $21.4 Million
1,532,113 Added 1442.5%
1,638,325 $13.4 Million
Q1 2022

May 16, 2022

SELL
$12.15 - $35.28 $610,999 - $1.77 Million
-50,288 Reduced 32.13%
106,212 $1.29 Million
Q4 2021

Feb 14, 2022

BUY
$30.49 - $48.49 $566,717 - $901,283
18,587 Added 13.48%
156,500 $5.34 Million
Q3 2021

Nov 09, 2021

BUY
$41.66 - $52.52 $570,367 - $719,051
13,691 Added 11.02%
137,913 $6.65 Million
Q2 2021

Aug 13, 2021

SELL
$36.62 - $51.69 $1.15 Million - $1.62 Million
-31,408 Reduced 20.18%
124,222 $5.61 Million
Q1 2021

May 13, 2021

BUY
$41.56 - $59.88 $832,114 - $1.2 Million
20,022 Added 14.76%
155,630 $7.51 Million
Q4 2020

Feb 11, 2021

SELL
$36.08 - $56.47 $253,137 - $396,193
-7,016 Reduced 4.92%
135,608 $7.3 Million
Q3 2020

Nov 12, 2020

BUY
$33.26 - $40.48 $924,561 - $1.13 Million
27,798 Added 24.21%
142,624 $5.26 Million
Q2 2020

Aug 12, 2020

BUY
$24.21 - $31.02 $322,937 - $413,775
13,339 Added 13.14%
114,826 $3.56 Million
Q1 2020

May 13, 2020

SELL
$20.5 - $34.53 $940,847 - $1.58 Million
-45,895 Reduced 31.14%
101,487 $2.8 Million
Q4 2019

Feb 10, 2020

BUY
$18.96 - $29.84 $228,335 - $359,363
12,043 Added 8.9%
147,382 $4.31 Million
Q3 2019

Nov 14, 2019

BUY
$19.12 - $26.24 $540,426 - $741,673
28,265 Added 26.4%
135,339 $2.59 Million
Q2 2019

Aug 14, 2019

BUY
$19.57 - $24.1 $832,057 - $1.02 Million
42,517 Added 65.86%
107,074 $2.35 Million
Q1 2019

May 15, 2019

SELL
$12.14 - $20.46 $636,876 - $1.07 Million
-52,461 Reduced 44.83%
64,557 $1.32 Million
Q4 2018

Feb 14, 2019

BUY
$11.24 - $18.5 $573,307 - $943,611
51,006 Added 77.27%
117,018 $1.48 Million
Q3 2018

Nov 14, 2018

BUY
$12.5 - $15.38 $17,362 - $21,362
1,389 Added 2.15%
66,012 $1.01 Million
Q2 2018

Aug 14, 2018

BUY
$7.99 - $14.05 $90,510 - $159,158
11,328 Added 21.26%
64,623 $846,000
Q1 2018

May 15, 2018

BUY
$7.23 - $8.76 $305,930 - $370,670
42,314 Added 385.34%
53,295 $435,000
Q4 2017

Feb 14, 2018

SELL
$8.02 - $11.18 $207,814 - $289,696
-25,912 Reduced 70.24%
10,981 $98,000
Q3 2017

Nov 14, 2017

BUY
$9.11 - $11.26 $336,095 - $415,415
36,893
36,893 $410,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.08B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.